137 related articles for article (PubMed ID: 38159203)
1. A new antiviral hypothesis and radioactive iodine therapy to other cancers, such as breast cancer, lung cancer, and glioblastoma multiforme (GBM)?
Czarnywojtek A; Gut P; Borowska M; Sawicka-Gutaj N; Caputa P; Kos-Kudła B; Ruchała M; Dworacka M
Endokrynol Pol; 2023; 74(6):. PubMed ID: 38159203
[TBL] [Abstract][Full Text] [Related]
2. The sodium iodide symporter (NIS) as theranostic gene: its emerging role in new imaging modalities and non-viral gene therapy.
Kitzberger C; Spellerberg R; Morath V; Schwenk N; Schmohl KA; Schug C; Urnauer S; Tutter M; Eiber M; Schilling F; Weber WA; Ziegler S; Bartenstein P; Wagner E; Nelson PJ; Spitzweg C
EJNMMI Res; 2022 May; 12(1):25. PubMed ID: 35503582
[TBL] [Abstract][Full Text] [Related]
3. A NEW HYPOTHESIS IN THE TREATMENT OF RECURRENT GLIOBLASTOMA MULTIFORME (GBM). PART 1: INTRODUCTION.
Czarnywojtek A; Gut P; Borowska M; Dyrka K; Ruchała M; Ferlito A
Pol Merkur Lekarski; 2023; 51(4):430-432. PubMed ID: 37756465
[TBL] [Abstract][Full Text] [Related]
4. Standard therapy or additionally radioactive iodine (131I) therapy; which will stop the recurrence of glioblastoma multiforme (GBM)?
Czarnywojtek A; Gut P; Dyrka K; Sowiński J; Sawicka-Gutaj N; Katulska K; Stajgis P; Wykrętowicz M; Moskal J; Kościński J; Pietrończyk K; Graczyk P; Krawczyński MR; Florek E; Szczepanek-Parulska E; Ruchała M; Ferlito A
Endokrynol Pol; 2024; 75(2):130-139. PubMed ID: 38646982
[TBL] [Abstract][Full Text] [Related]
5. [
Jiang H; DeGrado TR
Theranostics; 2018; 8(14):3918-3931. PubMed ID: 30083270
[TBL] [Abstract][Full Text] [Related]
6. Establishment of radioactive astatine and iodine uptake in cancer cell lines expressing the human sodium/iodide symporter.
Petrich T; Helmeke HJ; Meyer GJ; Knapp WH; Pötter E
Eur J Nucl Med Mol Imaging; 2002 Jul; 29(7):842-54. PubMed ID: 12111124
[TBL] [Abstract][Full Text] [Related]
7. A NEW HYPOTHESIS IN THE TREATMENT OF RECURRENT GLIOBLASTOMA MULTIFORME (GBM). PART 2: IS THERE AN ALTERNATIVE THERAPY OPTION IN RECURRENT GM WHEN ALL STANDARD TREATMENTS HAVE BEEN EXHAUSTED?
Czarnywojtek A; Gut P; Sowiński J; Ruchała M; Ferlito A; Dyrka K
Pol Merkur Lekarski; 2023; 51(4):433-435. PubMed ID: 37756466
[TBL] [Abstract][Full Text] [Related]
8. Mesenchymal Stem Cell-mediated Image-guided Sodium Iodide Symporter (NIS) Gene Therapy Improves Survival of Glioblastoma-bearing Mice.
Kitzberger C; Spellerberg R; Han Y; Schmohl KA; Stauss C; Zach C; Kälin RE; Multhoff G; Eiber M; Schilling F; Glass R; Weber WA; Wagner E; Nelson PJ; Spitzweg C
Clin Cancer Res; 2023 Mar; 29(5):930-942. PubMed ID: 36516189
[TBL] [Abstract][Full Text] [Related]
9. Preclinical efficacy of the oncolytic measles virus expressing the sodium iodide symporter in iodine non-avid anaplastic thyroid cancer: a novel therapeutic agent allowing noninvasive imaging and radioiodine therapy.
Reddi HV; Madde P; McDonough SJ; Trujillo MA; Morris JC; Myers RM; Peng KW; Russell SJ; McIver B; Eberhardt NL
Cancer Gene Ther; 2012 Sep; 19(9):659-65. PubMed ID: 22790962
[TBL] [Abstract][Full Text] [Related]
10. The importance of sodium/iodide symporter (NIS) for thyroid cancer management.
Carvalho DP; Ferreira AC
Arq Bras Endocrinol Metabol; 2007 Jul; 51(5):672-82. PubMed ID: 17891230
[TBL] [Abstract][Full Text] [Related]
11. Sodium/iodide symporter: a key transport system in thyroid cancer cell metabolism.
Filetti S; Bidart JM; Arturi F; Caillou B; Russo D; Schlumberger M
Eur J Endocrinol; 1999 Nov; 141(5):443-57. PubMed ID: 10576759
[TBL] [Abstract][Full Text] [Related]
12. The sodium iodide symporter (NIS): novel applications for radionuclide imaging and treatment.
Spitzweg C; Nelson PJ; Wagner E; Bartenstein P; Weber WA; Schwaiger M; Morris JC
Endocr Relat Cancer; 2021 Sep; 28(10):T193-T213. PubMed ID: 34259647
[TBL] [Abstract][Full Text] [Related]
13. Sodium iodide symporter: its role in nuclear medicine.
Chung JK
J Nucl Med; 2002 Sep; 43(9):1188-200. PubMed ID: 12215558
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of [
Niu M; Qin J; Wang L; He Y; Tian C; Chen Y; Huang P; Peng Z
Mol Imaging; 2022; 2022():2679260. PubMed ID: 35330799
[TBL] [Abstract][Full Text] [Related]
15. Effective radiovirotherapy for malignant gliomas by using oncolytic measles virus strains encoding the sodium iodide symporter (MV-NIS).
Opyrchal M; Allen C; Iankov I; Aderca I; Schroeder M; Sarkaria J; Galanis E
Hum Gene Ther; 2012 Apr; 23(4):419-27. PubMed ID: 22185260
[TBL] [Abstract][Full Text] [Related]
16. Initial Clinical Investigation of [18F]Tetrafluoroborate PET/CT in Comparison to [124I]Iodine PET/CT for Imaging Thyroid Cancer.
Samnick S; Al-Momani E; Schmid JS; Mottok A; Buck AK; Lapa C
Clin Nucl Med; 2018 Mar; 43(3):162-167. PubMed ID: 29356744
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-6-controlled, mesenchymal stem cell-based sodium/iodide symporter gene therapy improves survival of glioblastoma-bearing mice.
Kitzberger C; Shehzad K; Morath V; Spellerberg R; Ranke J; Steiger K; Kälin RE; Multhoff G; Eiber M; Schilling F; Glass R; Weber WA; Wagner E; Nelson PJ; Spitzweg C
Mol Ther Oncolytics; 2023 Sep; 30():238-253. PubMed ID: 37701849
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of sodium/iodide symporter expression in thyroid and breast cancer.
Kogai T; Taki K; Brent GA
Endocr Relat Cancer; 2006 Sep; 13(3):797-826. PubMed ID: 16954431
[TBL] [Abstract][Full Text] [Related]
19. Imaging and targeted therapy of pancreatic ductal adenocarcinoma using the theranostic sodium iodide symporter (NIS) gene.
Schmohl KA; Gupta A; Grünwald GK; Trajkovic-Arsic M; Klutz K; Braren R; Schwaiger M; Nelson PJ; Ogris M; Wagner E; Siveke JT; Spitzweg C
Oncotarget; 2017 May; 8(20):33393-33404. PubMed ID: 28380420
[TBL] [Abstract][Full Text] [Related]
20. Dual EGFR- and TfR-targeted gene transfer for sodium iodide symporter gene therapy of glioblastoma.
Spellerberg R; Benli-Hoppe T; Kitzberger C; Hageneier M; Schwenk N; Öztürk Ö; Steiger K; Multhoff G; Eiber M; Schilling F; Weber WA; Kälin RE; Glass R; Nelson PJ; Wagner E; Spitzweg C
Mol Ther Oncolytics; 2022 Dec; 27():272-287. PubMed ID: 36458201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]